A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Dettagli Bibliografici
Autore principale:	Shehab, Habibul Mohsin
Altri autori:	Yasmin, Hasina
Natura:	Tesi
Lingua:	English
Pubblicazione:	Brac University 2024
Soggetti:	Pharmacovigilance Rivastigmine Alzheimer's disease Dementia Pharmacoepidemiology. Mortality. Alzheimer's disease.
Accesso online:	http://hdl.handle.net/10361/22683

Documenti analoghi

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
di: Tabassum, Nadira
Pubblicazione: (2024)

Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
di: Mahee, Sadique Abdal
Pubblicazione: (2024)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
di: Alim, Abdul
Pubblicazione: (2023)

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
di: Karmaker, Swastika
Pubblicazione: (2024)

A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
di: Jahan, Nusrat
Pubblicazione: (2023)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
di: Ishrat, Nowshin
Pubblicazione: (2024)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
di: Bakar, Osama Bin Abu
Pubblicazione: (2024)

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
di: Chowdhury, Sariya Uzrat
Pubblicazione: (2022)

Role of protein’s and future treatment options for Alzheimer’s Disease
di: Islam, Md. Irfath
Pubblicazione: (2023)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
di: Saha, Bithi Rani
Pubblicazione: (2023)

Alzheimer's disease and marriage : an intimate account /
di: Wright, Lore K.
Pubblicazione: (1993)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
di: Hassan, Md. Muhtaz
Pubblicazione: (2020)

Glymphatic system: a pathway for managing endogenous metabolites in CNS
di: Tasneem, Sadia
Pubblicazione: (2021)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
di: Tamanna, Mst. Taskia
Pubblicazione: (2023)

Emerging therapies of Alzheimer’s disease: a comprehensive review
di: Tasin, Md Abtahi
Pubblicazione: (2023)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
di: Aziz, Farhin
Pubblicazione: (2019)

An ambient assisted living system for Alzheimer’s patients
di: Abedin, Minhajul, et al.
Pubblicazione: (2023)

Prospective detection methods for Tau protein: an important biomarker for Alzheimer’s disease
di: Afra, Sumaiya
Pubblicazione: (2022)

Marine compounds in the treatment of Alzheimer’s disease
di: Parveen, Sanjana
Pubblicazione: (2022)

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
di: Halim, Rabea
Pubblicazione: (2022)

Exploring the role of programmed cell death protein 1 in alzheimer’s disease associated autoimmunity
di: Aana, Afsara Sumon
Pubblicazione: (2021)

Exploring Alzheimer's disease prediction with XAI in various neural network models
di: Rahman, Quazi Ashikur, et al.
Pubblicazione: (2022)

Epigenetic dysregulation in neurodegenerative diseases and potential treatment
di: Mostofa, Golam
Pubblicazione: (2022)

Gene editing for neurodegenerative diseases-A review
di: Sharna, Anika Islam
Pubblicazione: (2023)

A review on adult neurogenesis in Alzheimer’s disease
di: Akter, Moriam
Pubblicazione: (2022)

Potential treatments for epigenetic dysregulation in neurological diseases
di: Zaman, Rubaiyat
Pubblicazione: (2024)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
di: Haque, Mushfiqul
Pubblicazione: (2019)

Federated GAN based biomedical image augmentation and classification for Alzheimer’s disease
di: Roy, Aditya, et al.
Pubblicazione: (2023)

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
di: Dey, Manashi
Pubblicazione: (2024)

An efficient deep learning approach for detecting Alzheimer’s disease using brain images
di: Sani, Mehedi Hasan, et al.
Pubblicazione: (2022)

Anti-alzheimer and antioxidant activity of celastrus paniculatus seed
di: Alam, Badrul, et al.
Pubblicazione: (2016)

Role of circular RNA in neurological disease
di: Salsabil, Labiba
Pubblicazione: (2024)

Design and evaluation of convolutional neural network for detection of Alzheimer’s disease using MRI data
di: Mahbub, Riasat, et al.
Pubblicazione: (2022)

Skeleton /
di: Parkin, Peter

A review on interrelation among post-authorisation study, regulatory action and pharmacogenetics in pharmacovigilance
di: Nusrat, Tanzina
Pubblicazione: (2019)

হার্ট, ব্লাড, ফুড /
di: কাসেম, এম এ

Antihypertensive drugs and risk of cancer: A pharmacovigilance study
di: Rahman, Ahadina
Pubblicazione: (2018)

Management of Diabetes patients during COVID-19
di: Pantho, G. M. Golam Mehebub
Pubblicazione: (2021)

Pharmacoepidemiology and pharmacovigilance : synergistic tools to better Investigate drug safety /
di: Nour, Sabrina
Pubblicazione: (2019)

Detection of alzheimer's disease using deep learning
di: Hasan, Mahmudul, et al.
Pubblicazione: (2021)